Stereotactic ablative radiotherapy for oligometastatic prostate cancer

Keyphrases

• Biochemical Control 33%
• Cancer Disease 33%
• Castration-resistant 33%
• Castration-sensitive 33%
• Clinical Outcomes 33%
• Clinical Setting 33%
• Functional Imaging 33%
• Hormonal Therapy 33%
• In(III) 33%
• Local Control 33%
• Nodal Metastasis 33%
• Oligometastatic 33%
• Oligometastatic Prostate Cancer 100%
• Oligoprogressive Disease 33%
• Oligorecurrent 33%
• Osseous 33%
• Prostate 33%
• Prostate Cancer 33%
• Prostate Cancer Patients 33%
• Stereotactic Ablative Radiotherapy 100%
• Stereotactic Body Radiotherapy 100%
• Systemic Therapy 66%
• Total Dose 33%
• Volumetric Modulated Arc Therapy 33%

Medicine and Dentistry

• Diseases 25%
• Functional Imaging 25%
• Hormone Therapy 25%
• Nodal Metastasis 25%
• Prostate Cancer 100%
• Radiation Therapy 100%
• Stereotactic Body Radiation Therapy 75%
• Systemic Therapy 50%
• Volumetric Modulated Arc Therapy 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 25%
• Hormone Cancer Therapy 25%
• Prostate Cancer 100%